Author:
Alex Anitha B.,Baucum Anthony J.,Wilcox Karen S.
Abstract
Conantokin G (Con G), derived from the venom of Conus geographus, is the most characterized natural peptide antagonist targeted to N-methyl-d-aspartate (NMDA) receptors. Although Con G is known to bind to the glutamate binding site on the NR2 subunit of the receptor, it is unclear whether it can allosterically modulate the function of the receptor through the glycine binding site on the NR1 subunit. This study was designed to evaluate the action of Con G on NMDA receptor–mediated spontaneous excitatory postsynaptic currents (sEPSCs) and its modulation by glycine in cultured cortical neurons (13–19 days in vitro) using the whole cell patch-clamp technique. Con G inhibited NMDA receptor–mediated sEPSCs in a concentration-dependent manner. Also, the potency of Con G decreased as a function of time in culture. The inhibition of EPSCs observed after application of Con G in the presence of high (10 μM) and nominal (no added) concentrations of glycine was not different at 13 days in vitro (DIV). Furthermore, similar results were obtained with experiments on Con G–induced inhibition of NMDA-evoked whole cell currents. These results indicate that glycine concentrations do not have a direct effect on Con G–induced inhibition of NMDA currents. In addition, age dependency in the action of Con G on cortical neurons in vitro suggests that this model system would be useful in examining the effects of different agonists/antagonists on native synaptic NMDA receptors.
Publisher
American Physiological Society
Subject
Physiology,General Neuroscience
Reference46 articles.
1. Development and Subunit Composition of Synaptic NMDA Receptors in the Amygdala: NR2B Synapses in the Adult Central Amygdala
2. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs
3. Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism
4. Brimecombe JC, Gallagher MJ, Lynch DR, and Aizenman E. An NR2B point mutation affecting haloperidol and CP101, 606 sensitivity of single recombinant N-Methyl-D-Aspartate receptors. J Pharmacol Exp Ther 286: 627–634, 1998.
5. Danyz W and Parsons CG. Glycine and N-Methyl-D-Aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50: 597–664, 1998.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献